The protective effect of a Toxoplasma gondii SAG1 plasmid DNA vaccine in mice is enhanced with IL-18

Research in Veterinary Science

Volumn 89, Issue 1, 2010, Pages 93-97

  Liu, Quan ^a   Shang, Limin ^a   Jin, Hongtao ^a   Wei, Feng ^b   Zhu, Xing Quan ^c   Gao, Hongwei ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b JILIN AGRICULTURAL UNIVERSITY   (China)

^c SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

IL 18; Immunity; TgSAG1; Toxoplasma gondii

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 18; INTERLEUKIN 2; PLASMID DNA; PROTOZOON ANTIBODY; TOXOPLASMA GONDII SURFACE ANTIGEN 1 VACCINE; TOXOPLASMA GONDII VACCINE; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA IMMUNIZATION; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; INFECTION PREVENTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; RECOMBINANT PLASMID; SURVIVAL RATE; TH1 CELL; TOXOPLASMA GONDII; TOXOPLASMOSIS; TREATMENT DURATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CELL PROLIFERATION; CYTOKINES; INTERLEUKIN-18; MICE; PLASMIDS; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; SPLEEN; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; VACCINES, DNA;

ANIMALIA; MURINAE; MUS; TOXOPLASMA GONDII;

EID: 77952886004     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2010.01.007     Document Type: Article

References (33)

1. Angus C.W., Klivington-Evans D., Dubey J.P., Kovacs J.A. Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents. The Journal of Infectious Diseases 2000, 181:317-324.
2. Cai G., Kastelein R., Hunter C.A. Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii. Infection and Immunity 2000, 68:6932-6938.
3. Chen G., Chen H., Guo H., Zheng H. Protective effect of DNA-mediated immunization with a combination of SAG1 and IL-2 gene adjuvant against infection of Toxoplasma gondii in mice. Chinese Medical Journal (English) 2002, 115:1448-1452.
4. Couper K.N., Nielsen H.V., Petersen E., Roberts F., Roberts C.W., Alexander J. DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission. Vaccine 2003, 21:2813-2820.
5. Cui Y.L., He S.Y., Xue M.F., Zhang J., Wang H.X., Yao Y. Protective effect of a multiantigenic DNA vaccine against Toxoplasma gondii with co-delivery of IL-12 in mice. Parasite Immunology 2008, 30:309-313.
6. Darcy F., Maes P., Gras-Masse H., Auriault C., Bossus M., Deslee D., Godard I., Cesbron M.F., Tartar A., Capron A. Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii P30 antigen. The Journal of Immunology 1992, 149:3636-3641.
7. Dhama K., Mahendran M., Gupta P.K., Rai A. DNA vaccines and their applications in veterinary practice: current perspectives. Veterinary Research Communications 2008, 32:341-356.
8. Dinarello C.A. Interleukin-18. Methods 1999, 19:121-132.
9. Dubey J.P., Hill D.E., Jones J.L., Hightower A.W., Kirkland E., Roberts J.M., Marcet P.L., Lehmann T., Vianna M.C., Miska K., Sreekumar C., Kwok O.C., Shen S.K., Gamble H.R. Prevalence of viable Toxoplasma gondii in beef, chicken, and pork from retail meat stores in the United States: risk assessment to consumers. Journal of Parasitology 2005, 91:1082-1093.
10. Dubey J.P., Jones J.L. Toxoplasma gondii infection in humans and animals in the United States. International Journal for Parasitology 2008, 38:1257-1278.
11. El-Malky M., Shaohong L., Kumagai T., Yabu Y., Noureldin M.S., Saudy N., Maruyama H., Ohta N. Protective effect of vaccination with Toxoplasma lysate antigen and CpG as an adjuvant against Toxoplasma gondii in susceptible C57BL/6 mice. Microbiology and Immunology 2005, 49:639-646.
12. Elsheikha H.M. Congenital toxoplasmosis: priorities for further health promotion action. Public Health 2008, 122:335-353.
13. Fachado A., Rodriguez A., Angel S.O., Pinto D.C., Vila I., Acosta A., Amendoeira R.R., Lannes-Vieira J. Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice. Vaccine 2003, 21:1327-1335.
14. Gazzinelli R.T., Wysocka M., Hayashi S., Denkers E.Y., Hieny S., Caspar P., Trinchieri G., Sher A. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. The Journal of Immunology 1994, 153:2533-2543.
15. Grim K.C., McCutchan T., Li J., Sullivan M., Graczyk T.K., McConkey G., Cranfield M. Preliminary results of an anticircumsporozoite DNA vaccine trial for protection against avian malaria in captive African black-footed penguins (Spheniscus demersus). Journal of Zoo and Wildlife Medicine 2004, 35:154-161.
16. Howe D.K., Sibley L.D. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. The Journal of Infectious Diseases 1995, 172:1561-1566.
17. Innes E.A., Vermeulen A.N. Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora. Parasitology 2006, 133:S145-168.
18. Liddell S., Parker C., Vinyard B., Jenkins M., Dubey J.P. Immunization of mice with plasmid DNA coding for NcGRA7 or NcsHSP33 confers partial protection against vertical transmission of Neospora caninum. Journal of Parasitology 2003, 89:496-500.
19. Liu Q., Gao S., Jiang L., Shang L., Men J., Wang Z., Zhai Y., Xia Z., Hu R., Zhang X., Zhu X.Q. A recombinant pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB/c mice. Microbes and Infection 2008, 10:1355-1362.
20. Liu Q., Wei F., Gao S., Jiang L., Lian H., Yuan B., Yuan Z., Xia Z., Liu B., Xu X., Zhu X.Q. Toxoplasma gondii infection in pregnant women in China. Transactions of the Royal Society of Tropical Medicine and Hygiene 2009, 103:162-166.
21. Marshall D.J., Rudnick K.A., McCarthy S.G., Mateo L.R., Harris M.C., McCauley C., Snyder L.A. Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccine. Vaccine 2006, 24:244-253.
22. Mordue D.G., Monroy F., La Regina M., Dinarello C.A., Sibley L.D. Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. The Journal of Immunology 2001, 167:4574-4584.
23. Nakanishi K., Yoshimoto T., Tsutsui H., Okamura H. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine and Growth Factor Reviews 2001, 12:53-72.
24. Nielsen H.V., Lauemoller S.L., Christiansen L., Buus S., Fomsgaard A., Petersen E. Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene. Infection and Immunity 1999, 67:6358-6363.
25. Salagianni M., Wong K.L., Thomas M.J., Noble A., Kemeny D.M. An essential role for IL-18 in CD8 T cell-mediated suppression of IgE responses. The Journal of Immunology 2007, 178:4771-4778.
26. Sher A., Collazzo C., Scanga C., Jankovic D., Yap G., Aliberti J. Induction and regulation of IL-12-dependent host resistance to Toxoplasma gondii. Immunologic Research 2003, 27:521-528.
27. Wang H., Liu Q., Liu K., Zhong W., Gao S., Jiang L., An N. Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii. Parasitology International 2007, 56:263-268.
28. Waterborg J.H., Matthews H.R. The Lowry method for protein quantitation. Methods in Molecular Biology 1994, 32:1-4.
29. Wei F., Liu Q., Gao S., Shang L., Zhai Y., Men J., Jiang L., Zhu X.Q., Fu Z., Shi Y., Xia Z., Lin J. Enhancement by IL-18 of the protective effect of a Schistosoma japonicum 26kDa GST plasmid DNA vaccine in mice. Vaccine 2008, 26:4145-4149.
30. Wilson D.C., Matthews S., Yap G.S. IL-12 signaling drives CD8+ T cell IFN-gamma production and differentiation of KLRG1+ effector subpopulations during Toxoplasma gondii Infection. The Journal of Immunology 2008, 180:5935-5945.
31. Xue M., He S., Zhang J., Cui Y., Yao Y., Wang H. Comparison of cholera toxin A2/B and murine interleukin-12 as adjuvants of Toxoplasma multi-antigenic SAG1-ROP2 DNA vaccine. Experimental Parasitology 2008, 119:352-357.
32. Yuan Z., Gao S., Liu Q., Xia X., Liu X., Liu B., Hu R. Toxoplasma gondii antibodies in cancer patients. Cancer Letters 2007, 254:71-74.
33. Zimmermann S., Dalpke A., Heeg K. CpG oligonucleotides as adjuvant in therapeutic vaccines against parasitic infections. International Journal of Medical Microbiology 2008, 298:39-44.